TCTR20180626002已完成3 期
Comparative study between Entecavir and Tenofovir in the treatment of chronic hepatitis B infection in Thai patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 442
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Chronic hepatitis B patients who had indication to receive antiviral treatment
排除标准
- •1 History of malignancy except early stage skin cancer
- •2 Decompensated cirrhosis
- •3 Creatinine clearance less than 50 ml/min
- •4 Kanofsky performance status less than 60
- •5 Pregnancy or lactation
研究者
相似试验
进行中（未招募）
不适用
Comparative Study of Entecavir vs Adefovir vs the Combination in Lamivudine- Refractory Chronic Hepatitis B Subjects The DEFINE Study Revised Protocol 01 - The DEFINE StudyEUCTR2006-000422-31-ITBristol-Myers Squibb International Corporation462
进行中（未招募）
不适用
A Comparative Study of Entecavir vs Adefovir Plus Lamivudine vs CombinationEntecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: TheDEFINE StudyRevised Protocol 02, incorporating protocol amendment 02 (Version 2.0, date 23-Jan-2007), protocol amendment 03 (Version 4.0, date 07-Nov-2007) and Administrative Letter 01. - The DEFINE StudyEUCTR2006-000422-31-GRBristol-Myers Squibb International Corporation462
已完成
2 期
Clinical trial study on the therapeutic effect of Tenofovir besides routine drug regime (standard of care) in patients with Coronavirus disease 2019 (COVID-19)covid-19.Covid-19, confirmed cases, positive test resultU07.1IRCT20200422047168N1Ahvaz University of Medical Sciences60
招募中
不适用
Efficacy of entecavir-to-tenofovir switching treatment to attain a drug-free state in chronic hepatitis B: a randomized controlled trialchronic hepatitis BJPRN-UMIN000021793Department of Hepatology, Osaka Metropolitan University90
招募中
不适用
ong-term Safety of Entecavir and Tenofovir in Patients with Chronic Hepatitis B virus infectioKCT0003487Hanyang University Seoul Hospital2,000